[go: up one dir, main page]

ATE478941T1 - Vorläuferzellen aus der wharton sulze von humanen nabelschnüren - Google Patents

Vorläuferzellen aus der wharton sulze von humanen nabelschnüren

Info

Publication number
ATE478941T1
ATE478941T1 AT04709560T AT04709560T ATE478941T1 AT E478941 T1 ATE478941 T1 AT E478941T1 AT 04709560 T AT04709560 T AT 04709560T AT 04709560 T AT04709560 T AT 04709560T AT E478941 T1 ATE478941 T1 AT E478941T1
Authority
AT
Austria
Prior art keywords
wharton
julk
human umbilical
cells
umbilical cords
Prior art date
Application number
AT04709560T
Other languages
English (en)
Inventor
John E Davies
Dolores Baksh
Rahul Sarugaser
Morris Hosseini
Antony David Sutton Lickorish
Original Assignee
John E Davies
Dolores Baksh
Rahul Sarugaser
Morris Hosseini
Antony David Sutton Lickorish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John E Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony David Sutton Lickorish filed Critical John E Davies
Application granted granted Critical
Publication of ATE478941T1 publication Critical patent/ATE478941T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT04709560T 2003-02-11 2004-02-10 Vorläuferzellen aus der wharton sulze von humanen nabelschnüren ATE478941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44627503P 2003-02-11 2003-02-11
PCT/CA2004/000182 WO2004072273A1 (en) 2003-02-11 2004-02-10 Progenitor cells from wharton's jelly of human umbilical cord

Publications (1)

Publication Number Publication Date
ATE478941T1 true ATE478941T1 (de) 2010-09-15

Family

ID=32869477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04709560T ATE478941T1 (de) 2003-02-11 2004-02-10 Vorläuferzellen aus der wharton sulze von humanen nabelschnüren

Country Status (14)

Country Link
US (5) US7547546B2 (de)
EP (2) EP1594957B1 (de)
JP (1) JP4790592B2 (de)
KR (1) KR101077760B1 (de)
AT (1) ATE478941T1 (de)
AU (2) AU2004210891B2 (de)
BR (1) BRPI0407221A (de)
CA (1) CA2515469C (de)
DE (1) DE602004028803D1 (de)
ES (1) ES2351386T3 (de)
HK (1) HK1084417A1 (de)
IL (2) IL170221A (de)
PT (1) PT1594957E (de)
WO (1) WO2004072273A1 (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
DK1349918T3 (da) 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
KR101132545B1 (ko) * 2001-02-14 2012-04-02 안트로제네시스 코포레이션 산후 포유류의 태반, 이의 용도 및 태반 줄기세포
CA3046566A1 (en) * 2001-02-14 2002-08-22 Anthrogenesis Corporation Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
CA2515469C (en) 2003-02-11 2013-12-17 John E. Davies Progenitor cells from wharton's jelly of human umbilical cord
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US9579351B2 (en) 2003-06-27 2017-02-28 DePuy Synthes Products, Inc. Postpartum cells derived from placental tissue, and methods of making and using the same
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US8518390B2 (en) 2003-06-27 2013-08-27 Advanced Technologies And Regenerative Medicine, Llc Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8491883B2 (en) 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
AU2005273077B2 (en) * 2004-08-16 2011-02-24 Cellresearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
WO2006101548A2 (en) * 2004-12-21 2006-09-28 Ethicon, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060166361A1 (en) * 2004-12-21 2006-07-27 Agnieszka Seyda Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060153815A1 (en) * 2004-12-21 2006-07-13 Agnieszka Seyda Tissue engineering devices for the repair and regeneration of tissue
ES2621847T3 (es) * 2004-12-23 2017-07-05 DePuy Synthes Products, Inc. Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
WO2006071777A2 (en) * 2004-12-23 2006-07-06 Ethicon Incorporated Soft tissue repair and regeneration using postpartum-derived cells and cell products
WO2006071773A2 (en) * 2004-12-23 2006-07-06 Ethicon Incoporated Treatment of osteochondral diseases using postpartum-derived cells and products thereof
DK1835924T3 (da) 2004-12-23 2013-11-04 Ethicon Inc Behandling af parkinsons sygdom og beslægtede sygdomme under anvendelse af postpartum opnåede celler
CA2856662C (en) 2005-10-13 2017-09-05 Anthrogenesis Corporation Immunomodulation using placental stem cells
CA2629283A1 (en) * 2005-11-14 2007-05-24 The New England Medical Center Hospitals, Inc. Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
JP5289970B2 (ja) 2005-12-16 2013-09-11 エシコン・インコーポレイテッド 組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
US8741638B2 (en) * 2005-12-19 2014-06-03 DePuy Synthes Products, LLC In vitro expansion of postpartum-derived cells in roller bottles
CN103173401A (zh) * 2005-12-22 2013-06-26 简·恩尼斯 来自冷冻的脐带组织的活细胞
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
AU2006330409B2 (en) * 2005-12-28 2012-07-19 Ethicon, Incorporated Treatment of peripheral vascular disease using postpartum-derived cells
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
PT2471906T (pt) 2005-12-29 2019-02-06 Celularity Inc Populações de células estaminais da placenta
CA2644508A1 (en) * 2006-03-01 2007-09-07 The Regenerative Medicine Institute Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
PT2029149T (pt) * 2006-05-05 2017-08-23 Tissue Regeneration Therapeutics Inc Células progenitoras imunopriviligiadas e moduladoras
WO2007146106A2 (en) * 2006-06-05 2007-12-21 Cryo- Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
US20080050814A1 (en) * 2006-06-05 2008-02-28 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of fetal placental cells
WO2007146123A2 (en) * 2006-06-09 2007-12-21 Anthrogenesis Corporation Placental niche and use thereof to culture stem cells
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
WO2008060037A1 (en) * 2006-11-15 2008-05-22 Seoul National University Industry Foundation Method for the simultaneous primary-isolation and expansion of endothelial stem/progenitor cell and mesenchymal stem cell derived from mammal including human umbilical cord
KR100902569B1 (ko) * 2007-01-19 2009-06-11 재단법인서울대학교산학협력재단 인간 탯줄 유래 중간엽 줄기세포 및 이의 확립방법
US20080152630A1 (en) * 2006-12-07 2008-06-26 Irene Ginis Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
CN101657206B (zh) 2007-02-12 2013-07-03 人类起源公司 利用胎盘干细胞治疗炎性疾病
WO2009021333A1 (en) * 2007-08-14 2009-02-19 Tissue Regeneration Therapeutics Inc. Blood vessel extraction from umbilical cord
US10925903B2 (en) 2007-09-13 2021-02-23 Reprobiogen Inc. Use of cells derived from first trimester umbilical cord tissue
US12129481B2 (en) 2007-09-13 2024-10-29 Reprobiogen Inc. Use of cells derived from first trimester umbilical cord tissue
MX2008005751A (es) * 2007-09-13 2009-04-16 Clifford L Librach Metodo de aislamiento y uso de celulas derivadas del tejido del cordon umbilical del primer trimestre.
EP3524253A1 (de) 2007-09-28 2019-08-14 Celularity, Inc. Tumorsuppression mit menschlichem plazentaperfusat und menschlichen natürlichen killerzellen eines zwischenproduktes aus der plazenta
EP2203186B1 (de) * 2007-10-05 2014-09-24 DePuy Synthes Products, LLC Reparatur und regeneration von nierengewebe mit zellen aus menschlicher nabelschnur
RU2461622C2 (ru) * 2007-11-28 2012-09-20 Огенодженесис, Инк. Биоинженерный конструкт для имплантации ткани и способ изготовления названного биоинженерного конструкта (варианты)
US8236538B2 (en) 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
KR20170005148A (ko) 2008-04-21 2017-01-11 티슈 리제너레이션 쎄라퓨틱스, 인코포레이티드 생물학적 또는 화학적 물질에 대한 예방 또는 치료를 위한 유전적으로 변형된 인간 탯줄 혈관주위 세포
MX339624B (es) 2008-08-20 2016-06-02 Anthrogenesis Corp Composiciones mejoradas de celulas y metodos para preparar las mismas.
WO2010021715A1 (en) 2008-08-20 2010-02-25 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
ES2426241T3 (es) 2008-08-22 2013-10-22 Anthrogenesis Corporation Métodos y composiciones para el tratamiento de defectos óseos con poblaciones de células placentarias
RU2562154C2 (ru) 2008-11-19 2015-09-10 Антродженезис Корпорейшн Амниотические адгезивные клетки
BRPI0923068B1 (pt) 2008-12-19 2021-05-25 Advanced Technologies And Regenerative Medicine, Llc Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
US8771677B2 (en) 2008-12-29 2014-07-08 Vladimir B Serikov Colony-forming unit cell of human chorion and method to obtain and use thereof
WO2010111663A1 (en) 2009-03-26 2010-09-30 Ethicon, Inc. Human umbilical cord tissue cells as therapy for alzheimer' s disease
SG181774A1 (en) * 2009-12-18 2012-07-30 Lifeline Cord Blood Bank Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue
CA2787050A1 (en) * 2010-01-14 2011-07-21 Organogenesis, Inc. Bioengineered tissue constructs and methods for producing and using thereof
EP3284818B1 (de) 2010-01-26 2022-03-09 Celularity Inc. Behandlung von knochenbedingten karzinomen mit plazentastammzellen
AU2010350075B2 (en) 2010-03-30 2016-03-03 Histocell, S.L. New biomaterial from Wharton's jelly umbilical cord
RS55287B1 (sr) 2010-04-07 2017-03-31 Anthrogenesis Corp Angiogeneza korišćenjem matičnih ćelija iz placente
TW201138792A (en) 2010-04-08 2011-11-16 Anthrogenesis Corp Treatment of sarcoidosis using placental stem cells
WO2011153205A1 (en) 2010-06-01 2011-12-08 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
AU2011279201B2 (en) 2010-07-13 2016-01-21 Celularity Inc. Methods of generating natural killer cells
EP2609425A1 (de) 2010-08-23 2013-07-03 President and Fellows of Harvard College Optogenetische sonden zur messung des membranpotenzials
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
WO2012166844A2 (en) 2011-06-01 2012-12-06 Anthrogenesis Corporation Treatment of pain using placental stem cells
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
PT2775928T (pt) 2011-11-08 2019-05-30 Auxocell Laboratories Inc Sistemas e métodos para processar células
US9611513B2 (en) 2011-12-23 2017-04-04 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue derived cells
EP2798058B1 (de) 2011-12-30 2017-10-18 Amit Patel Verfahren und zusammensetzungen für die klinische ableitung einer allogenen zelle und therapeutische verwendungen
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
WO2013149003A1 (en) 2012-03-28 2013-10-03 Purdue Research Foundation Methods and systems useful for foodborne pathogen detection
US9670457B2 (en) * 2012-05-08 2017-06-06 Stem Cell Reserve Lp Stem cells and matrix from cord tissue
EP2756754B1 (de) 2013-01-17 2017-01-04 Vita 34 Ag Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
CN105142651A (zh) 2013-02-05 2015-12-09 人类起源公司 来自胎盘的自然杀伤细胞
WO2014140921A2 (en) 2013-03-15 2014-09-18 Larsson Marcus Kare Torleif Cells, methods and apparatuses for umbilical cord blood collection and isolation of cells
US10400211B1 (en) 2014-04-28 2019-09-03 Donnie Rudd Cell composition for tissue regeneration
USD748462S1 (en) 2014-08-11 2016-02-02 Auxocell Laboratories, Inc. Centrifuge clip
US9993748B2 (en) 2014-08-11 2018-06-12 Auxocell Laboratories, Inc. Centrifuge clip and method
US10542743B2 (en) 2015-01-05 2020-01-28 Hygieia Therapeutics Sdn Bhd Isolation, expansion and characterization of wharton's jelly mesenchymal stem cells
WO2017053701A1 (en) 2015-09-23 2017-03-30 Osiris Therapeutics, Inc. Umbilical tissue compositions and methods of use
US11542473B2 (en) 2016-10-21 2023-01-03 Amniotics Ab Methods and compositions for generating hematopoietic cells
EP3704225B1 (de) * 2017-10-27 2023-10-11 Alis Pharma Ltd. Fetalgewebeextrakt, verfahren zu seiner herstellung und seine verwendung
JP7286651B2 (ja) 2017-12-22 2023-06-05 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 間葉系間質細胞及び臍帯から間葉系間質細胞を得るための方法
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
WO2020008139A1 (fr) 2018-07-02 2020-01-09 Vetbiobank Cellules stromales neonatales presentant une faible expression du cmh-i et leurs utilisations
WO2021003254A1 (en) * 2019-07-01 2021-01-07 Auxocell Laboratories, Inc. Cryopreservation medium comprising a tissue extract
AU2020368845A1 (en) 2019-10-18 2022-05-12 Amniotics Ab Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof
EP3909593A1 (de) 2020-05-15 2021-11-17 Rigshospitalet Stammzellen zur behandlung von hautläsionen
CA3232099A1 (en) 2021-09-23 2023-03-30 Adam Ezra Cohen Genetically encoded voltage indicators and uses thereof
WO2023223303A1 (en) 2022-05-20 2023-11-23 Alt Atlas Ltd. Novel cell lines and systems and methods for a machine learning manufacturing software platform that optimize unique functional ingredients and solutions for the biotech and foodtech industries

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2578743B3 (fr) * 1985-03-13 1987-06-12 Bontemps Raymond Procede de fabrication d'une preparation medicamenteuse a base de substance mesenchymateuse du type microsepteurs
SU1708328A1 (ru) * 1989-07-11 1992-01-30 Кемеровский государственный медицинский институт Способ изготовлени сосудистого протеза
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US20050158289A1 (en) 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
CA2852534A1 (en) * 1999-08-05 2001-02-15 Abt Holding Company Multipotent adult stem cells and methods for isolation
US20020045260A1 (en) * 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
EP1383869B1 (de) 2001-04-24 2009-06-10 Dolores Baksh Vorläuferzellpopulationen, deren expansion und die entstehung von nicht-hämatopoetischen zelltypen daraus
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
US20030161818A1 (en) * 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
CA2515469C (en) 2003-02-11 2013-12-17 John E. Davies Progenitor cells from wharton's jelly of human umbilical cord
WO2005001081A1 (en) 2003-06-27 2005-01-06 UNIVERSITé LAVAL Method of isolating cells from umbilical cord
US9579351B2 (en) 2003-06-27 2017-02-28 DePuy Synthes Products, Inc. Postpartum cells derived from placental tissue, and methods of making and using the same
US20080113434A1 (en) 2004-03-05 2008-05-15 Davies John E Serum-Free Suspension Culture System For Mesenchymal Progenitor Cells
CN103173401A (zh) 2005-12-22 2013-06-26 简·恩尼斯 来自冷冻的脐带组织的活细胞
CA2644508A1 (en) 2006-03-01 2007-09-07 The Regenerative Medicine Institute Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
PT2029149T (pt) 2006-05-05 2017-08-23 Tissue Regeneration Therapeutics Inc Células progenitoras imunopriviligiadas e moduladoras

Also Published As

Publication number Publication date
EP1594957B1 (de) 2010-08-25
AU2004210891B2 (en) 2008-09-25
JP2006517102A (ja) 2006-07-20
AU2004210891A1 (en) 2004-08-26
US20090269318A1 (en) 2009-10-29
HK1084417A1 (en) 2006-07-28
US9611456B2 (en) 2017-04-04
US9567564B2 (en) 2017-02-14
US20130259840A1 (en) 2013-10-03
ES2351386T3 (es) 2011-02-03
WO2004072273A1 (en) 2004-08-26
JP4790592B2 (ja) 2011-10-12
EP1594957A1 (de) 2005-11-16
AU2008261123A1 (en) 2009-01-15
US20160032241A1 (en) 2016-02-04
EP2277992A2 (de) 2011-01-26
US20170157180A1 (en) 2017-06-08
US7547546B2 (en) 2009-06-16
IL202331A (en) 2011-08-31
US20050148074A1 (en) 2005-07-07
PT1594957E (pt) 2010-11-30
US8481311B2 (en) 2013-07-09
EP2277992A3 (de) 2011-03-02
DE602004028803D1 (de) 2010-10-07
KR101077760B1 (ko) 2011-10-27
BRPI0407221A (pt) 2006-01-31
IL170221A (en) 2010-11-30
KR20050115862A (ko) 2005-12-08
CA2515469C (en) 2013-12-17
CA2515469A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
ATE478941T1 (de) Vorläuferzellen aus der wharton sulze von humanen nabelschnüren
DE60029566D1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DE69424861D1 (de) Geminivirus-basiertes-genexpressionsystem
CY1118167T1 (el) Πρωτογενη και εγγυς ηπατικα βλαστοκυτταρα
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
ES2056854T3 (es) Tiadiazinonas.
BR0211079A (pt) Processos para a modificação genética de células hematopoiéticas progenitoras e empregos das células modificadas
DE60135019D1 (de) Elektroverarbeitetes kollagen
NO20013770L (no) Metoder og blandinger for å öke antall hvite blodceller
FR09C0067I2 (fr) Agents contenant de l'acide carboxylique et leur utilisation dans la culture de plantes
BRPI0412871A (pt) combinações de substáncias ativas fungicidas
DE59712094D1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
ES2116496T3 (es) Proceso para la preparacion de 1,4-disubstituido-5(4h)-tetrazolinonas.
ATE501635T1 (de) Chemische hemmstoffe des mismatch-repair
DE60336187D1 (de) Verwendung von einem Extrakt von einem nicht-photosynthetischen faserigen Bakterium zur Beförderung der Herstellung von Superoxid-dismutase
DE60329747D1 (de) Vektoren mit beiden isoformen von beta-hexosaminidase
SE0203526L (sv) New use of dextran sulfate
ATE532883T1 (de) Voc-arme fettungsmittel, ihre verwendung in der herstellung und/oder behandlung von leder und häuten, sowie das ensprechende herstellungs- bzw. behandlungsverfahren
DK1366367T3 (da) Organtransplantatafstödning og tilknyttede tilstande
DE502004011187D1 (de) M-diaminobenzole und deren säureaddukte sowie deren verwendung in färbemitteln
DE60045663D1 (de) Rlichem interferon-alpha
WO2004000213A3 (en) Method for growing human organs, treating diseases, and increasing longevity
Houston For this cause
RU99111148A (ru) Глазные капли

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties